Monday, 16 September 2019

Pharma News

  • Hoya appoints new executive officer

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 May, 2014

    Singapore: Japan based Hoya Corporation has appointed Mr Augustine Yee as its executive officer, chief legal officer and head of corporate development and affairs. As the company's first c...Read more

  • Ninad Deshpanday is Kemwell R&D president

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 15 Feb, 2013

    Bangalore: India-based Kemwell Biopharma appointed Dr Ninad Deshpanday as president of R&D. Dr Deshpanday has over 22 years of experience in diverse international roles in the pharmaceu...Read more

  • China's Fosun strikes $534 mn deal with Swiss Sellas

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 25 Oct, 2013

    Singapore: In what could be a landmark deal, China's largest biotech company has struck a deal worth $534 million with Switzerland's specialty biopharmaceutical and clinical research giant,...Read more

  • Innovation in drug delivery system is in a constant state of evolution'

    Pharma |  Opinion | By Nandita Singh | 0 Comment | 14 Mar, 2012

    Ms Prasanna Vadhana Kannan is the industry analyst in medical devices & diagnostic imaging for Frost & Sullivan Asia Pacific. One of the notable advances transforming the field of ...Read more

  • Takeda's center among Chicago's top 100 workplaces

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 14 Nov, 2012

    Singapore: Takeda Pharmaceuticals' Deerfield campus has been listed among Chicago's top 100 workplaces by the Chicago Tribune. The list of the best places to work in the Chicago area is ba...Read more

  • Eisai seeks nod for Helicobacter Pylori treatment

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

    Singapore: Eisai, which has its headquarters in Tokyo, has submitted a marketing authorization application to Japan's Ministry of Health, Labor and Welfare for approval of two types of new ...Read more

  • Will Keryx's ferric citrate NDA get nod in Japan?

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jan, 2013

    Singapore: Keryx Biopharmaceuticals announced that its Japanese partner, Japan Tobacco (JT), has filed a New Drug Application (NDA) with the Japanese Ministry of Health, Labour and Welfare...Read more

  • Study shows effectiveness of MSD's Januvia

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jun, 2012

    Singapore: A new study published in Current Medical Research & Opinion (CMRO) showed that people with type 2 diabetes who chose to fast during Ramadan and were switched to MSD's Januvia...Read more

  • VM202 trial completes patient administration

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2013

    Singapore: ViroMed, a leading biotechnology company, announced the final enrollment and administration of 105 patients for the company's ongoing phase II clinical trial of VM202-DPN in US/K...Read more

  • FDA accepts sNDA for Astellas cancer drug

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 17 Jan, 2013

    Singapore: The US FDA has accepted Astellas Pharma's US subsidiary filing of a supplemental New Drug Application (sNDA) for Tarceva (erlotinib) for first-line use in people with locally adv...Read more

  • AstraZeneca, BMS gets FDA nod for diabetes drug

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 09 Jan, 2014

    Singapore: AstraZeneca and Bristol-Myers Squibb have recieved U.S. Food and Drug Administration (FDA) approval for diabetes drug Farxiga (dapagliflozin). AstraZeneca and Bristol-Myers Squi...Read more

  • EMA to review marketing plea for antipsychotic medication

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

    Singapore: The European Medicines Agency (EMA) has accepted the marketing authorization application for review of an atypical antipsychotic medication lurasidone hydrochloride. The product ...Read more

  • Leo launches psoriasis education program

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2013

    Singapore: Leo Pharma launched Psoriasis Coach All-Round Education (PsorCARE) program in Singapore on January 26, 2013. Developed by LEO Pharma Asia and PsorAsia, PsorCARE's goal is to enh...Read more

  • Chipscreen gets SFDA nod after accelerated review

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 17 Apr, 2013

    ‎Singapore: China-based Chipscreen Biosciences announced the achievement of the primary endpoint in the pivotal, registrational phase II Chipel trial of Chidamide (Epidaza), an orally...Read more

  • Bird flu cases erupt in Cambodia

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 04 Feb, 2013

    Singapore: Cambodia's Ministry of Health (MoH) has reported five new human cases of avian influenza (bird flu), which were confirmed positive for the H5N1 virus in January 2013. The five ...Read more

  • Indian pharma clocks 8.9% growth in June 2013: IMS

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2013

    New Delhi: The IMS Health Total Sales Audit (TSA) has released a report stating that the Indian pharmaceutical market has clocked a growth of 8.9 percent during the month of June 2013. The...Read more

  • Sanofi withdraws diabetes drug NDA in the US

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2013

    Singapore: Global pharmaceutical company, Sanofi has temporarily withdrawn new drug application (NDA) for lixisenatide in the US and plans to resubmit in 2015.Lixisenatide is approved in Eu...Read more

  • Antithrombotic drug market to be $24 bn by 2015

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Feb, 2013

    Singapore: Visiongain, a business information provider, estimates in its report 'Antithrombotic Drugs: World Market 2013-2023' that the global antithrombotic drug market to reach revenue of...Read more



Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls